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Abstract: Zika virus (ZIKV) was first discovered in 1947 in Africa. Since then, sporadic ZIKV infections
of humans have been reported in Africa and Asia. For a long time, this virus was mostly unnoticed
due to its mild symptoms and low fatality rates. However, during the 2015–2016 epidemic in Central
and South America, when millions of people were infected, it was discovered that ZIKV causes
microcephaly in the babies of mothers infected during pregnancy. An examination of the M and C
proteins of the ZIKV shell using the disorder predictor PONDR VLXT revealed that the M protein
contains relatively high disorder levels comparable only to those of the yellow fever virus (YFV).
On the other hand, the disorder levels in the C protein are relatively low, which can account for the
low case fatality rate (CFR) of this virus in contrast to the more virulent YFV, which is characterized
by high disorder in its C protein. A larger variation was found in the percentage of intrinsic disorder
(PID) in the C protein of various ZIKV strains. Strains of African lineage are characterized by higher
PIDs. Using both in vivo and in vitro experiments, laboratories have also previously shown that
strains of African origin have a greater potential to inflict higher fetal morbidity than do strains of
Asian lineage, with dengue-2 virus (DENV-2) having the least potential. Strong correlations were
found between the potential to inflict fetal morbidity and shell disorder in ZIKV (r2 = 0.9) and DENV-2
(DENV-2 + ZIKV, r2 = 0.8). A strong correlation between CFR and PID was also observed when
ZIKV was included in an analysis of sets of shell proteins from a variety of flaviviruses (r2 = 0.8).
These observations have potential implications for antiviral vaccine development and for the design
of cancer therapeutics in terms of developing therapeutic viruses that penetrate hard-to-reach organs.
Keywords: Zika; protein intrinsic disorder; shell disorder; dengue; virulence; microcephaly; vaccine;
yellow fever; morbidity; fetal
1. Introduction
The Zika virus (ZIKV) was first isolated in 1947 when three owl monkeys from the Zika Forest,
Uganda, were found to have a fever [1,2]. Even though the first human case was reported in 1952 and
although this virus has been circulating in Asia and Africa, very few ZIKV cases were noticed and
recorded before the 2015/2016 epidemic, since the symptoms were generally mild [1,3] and fatality was
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rare. In 2014, the first sign of an oncoming ZIKV epidemic appeared in French Polynesia with around
35,000 known cases of infection. This was followed by a full-blown epidemic in Latin and Central
America in 2015/2016, with approximately 1.5 million estimated cases in Brazil alone [3,4]. With such a
large number of infections, physicians were able to notice exceptionally large numbers of microcephaly
cases among the babies of women who were infected by ZIKV during their pregnancies [1,3,5,6].
Microcephaly refers to a condition in which a baby is born with a smaller than usual brain and head.
Further studies of ZIKV in laboratories using animal models confirmed the ability of ZIKV to penetrate
both the placenta and the brain [7–13].
ZIKV is a member of the genus Flavivirus, which encompasses a large variety of arthropod-borne
enveloped RNA viruses, including dengue virus (DENV), West Nile virus (WNV), and the notoriously
pathogenic yellow fever virus (YFV). Similarly to YFV and DENV, ZIKV is also spread by the mosquito,
Aedes aegypti [2,6,14]. A flavivirus genome encodes a polyprotein that includes 10 proteins, three
structural proteins (capsid (C), precursor membrane (PrM), and envelope (E) proteins), and seven
nonstructural (NS) proteins (NS1, NS2a, NS2b, NS3, NS4a, NS4b, and NS5) [14,15]. The immature
virion contains an abundance of PrM protein, which is cleaved during maturation, and only M remains
in a mature virion [16,17]. In a mature virion, the outermost shell contains E protein, which is followed
by a shell containing M and C proteins. In an immature virion, however, both E and PrM are contained
in the outer shell [16,17].
The results presented in this study pertain to the concept of protein intrinsic disorder, which is
related to proteins or protein segments that have no ordered structure, but this lack of structure can be
related to the function of these proteins [18–21]. Such proteins are often known by other names, such as
“natively unfolded” and “intrinsically unstructured” proteins [20,22]. The penetrance of disorder in the
proteins from flaviviruses and ZIKV has already been analyzed [23–25]. The abundance and specific
functionality of intrinsically disordered proteins in viral proteomes in general have been considered
in several large-scale computational studies [26,27] and have been specifically analyzed for human
papillomaviruses [28,29], different strains of the influenza virus [30], human immunodeficiency virus
type -1 (HIV-1) [31], human hepatitis C virus [32,33], Dengue virus [34], respiratory syncytial virus [35],
Chikungunya virus [36], and Alkhurma virus [37]. Furthermore, previous studies have found correlations
between virulence and the shell disorder of DENV and flaviviruses, although the sets used in those
studies did not include ZIKV proteins [2,14]. The shell proteins examined were M and C proteins,
and the highly pathogenic YFV was found to contain the highest levels of shell disorder among the
fairly large variety of flaviviruses looked at. Although ZIKV shell disorder has also been inspected
in other studies, a comparative analysis between flaviviruses and ZIKV strains with respect to shell
disorder and virulence has not been conducted as of yet. Intriguingly, while ZIKV is not known for its
virulence [5], there are distinct disparities in the levels of potential to cause fetal morbidity between
various ZIKV strains of different lineages [38,39]. However, no attempt has been made to correlate
fetal morbidity and shell disorder until now. The research conducted in this paper demonstrates not
only that ZIKV fits well within the previously observed correlations between flavivirus virulence and
shell disorder, but that the uniqueness of the ZIKV shell disorder pattern is consistent with the varying
levels of fetal morbidity caused by strains of different lineages.
2. Materials and Methods
The appropriate proteins and their sequences were carefully searched and checked upon
retrieval from UniProt (http://www.uniprot.org) or NCBI (http://www.ncbi.nlm.nih.gov/structure/).
After downloading the sequences and respective protein data bank (PDB) files, the necessary information
was imported into the database using tools implemented in JAVA [40]. The corresponding protein
sequences in FASTA format were fed into the PONDR VLXT neural network (http://www.pondr.com).
The results were given as scores from 0 to 1. Residues with scores of 0.5 and over represent disordered
residues [41,42]. An important ratio used in this and previous studies is the percentage of intrinsic
disorder (PID), which is defined as the number of residues predicted to be disordered in a protein
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chain divided by the total number of residues in the chain. The PID can range from 0% (perfectly
ordered) to 100% (totally disordered).
The predicted intrinsic disorder-related information was retrieved and fed into a MYSQL database
that has been mentioned in previous papers [40]. Another JAVA-DBI program then automatically
created codes that were readable in Jmol (www.jmol.com), which generated a 3D representation of
protein crystal structures with disorder annotations that could be visualized from the colors provided
by the codes. The Jmol software also required the respective PDB (protein data bank) files, which could
be obtained from NCBI, as mentioned above.
A PONDR VLXT predictor was used in this study, since it is one of the most informative tools
for structural proteins, namely for viral shells, where protein–protein interactions play vital roles in
order–disorder transitions [41–44]. It has successfully been utilized to study the shell disorder of a large
variety of viruses, including HIV, smallpox, and polio viruses [2,14,25,30,45–52]. PONDR represents a
suite of computational tools for sequence-only predictions of the intrinsic disorder predisposition of
query in proteins. PONDR VLXT was the earliest predictor created at the end of the last century [41,42].
It involves the use of neural networks that are trained to recognize protein sequences that are ordered
and those that are not [53]. Statistical methods, including regression analysis and analysis of variance
(ANOVA), were used to analyze the PONDR VLXT results along with data on virulence and morbidity.
The statistical package R version 3.6.0. [54] was used to obtain the results. Before obtaining the
necessary results, the respective codes had to be written in R.
3. Results
3.1. The Correlation between Shell Disorder in Flaviviruses and Zika and Virulence and Fetal Morbidity
While ZIKV is not known for its virulence, fetal morbidity, as already mentioned, is a threat from
ZIKV infection [1–3,6]. ZIKV strains are generally categorized as of African or Asian lineage, and the
epidemic that occurred in 2015–2016 involved Asian strains that had crossed the Pacific Ocean to
reach the Americas. At least two laboratories have found that ZIKV strains of African lineage are
more dangerous to fetuses than those of Asian lineage [38,55]. The classical isolate for the strains of
African lineage is MR-766, which was discovered in Uganda in 1947 [1,56]. A PID-based wide selection
of ZIKV strains and isolates allowed us to see that the strains can be divided into four groups that
are consistent with their lineages but that are independent of the dates of the isolates (Figure 1A and
Table 1). Interestingly, our results show that there are at least two MR-766 isolates from Uganda-1947
with distinct shell disorder features (Table 1). Furthermore, DENV-2 has also been shown to cause
microcephaly in fetuses and newborns, but to a lesser extent when compared to ZIKV [38,39,55].
This has been observed in several laboratories using in vivo and in vitro methods. Chicken liver cells,
human nerve cells, and mouse models were used, and the levels of destruction by ZIKV and DENV-2
were observed according to the amount of cells destroyed [38,39,55]. The PIDs of DENV-2 and ZIKV
are compared in Figure 1 and Table 1.
Various statistical methods were used to reaffirm not just the statistical significance of the grouping
by shell PID (especially the C protein), but also the statistical significance of a strong correlation
between the PID of the C protein and fetal morbidity, given the evidence of greater fetal morbidity in
infections by MR-766. Regression analyses and an ANOVA conducted on the data shown in Table 1
provided evidence that the shell PID differences between strains of the African and Asian lineages are
statistically significant (Table 1; regression: r2 = 0.9, F = 15, p < 0.01; one-way ANOVA with C PID as
the independent variable: F = 53, p < 0.01). When data related to DENV-2 were added to the analysis,
a strong correlation that was statistically significant was found (r2 = 0.8, F = 16, p < 0.01).
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Table 1. Percentages of intrinsic disorder (PIDs) of M and C shell proteins from Zika virus (ZIKV)
strains with UniProt accession. Differences between the shell disorder in Asian and African strains are
statistically significant (regression: r2 = 0.9, F = 15, p < 0.01; one-way analysis of variance (ANOVA) with
C percentage of intrinsic disorder (PID) as the sole independent variable: F = 11, p < 0.05). Higher PIDs
in C proteins were found in the African strains even as the PID levels could differ for C proteins in
strains from the same lineage. The regression was performed using the assumption that the African
strains have greater fetal morbidity than do the Asian strains [38,39,55].
Virus Lineage C PID d M PID d UniProt ID
Senegal 2001
Uganda 1947 (MR-766) a,b African strains 45.0 ± 0.1 28.0 ± 0.1
W8QFH2
Q32ZE1 a,b
Uganda 1947 (MR-766) a,c
Central African Rep 1976 African strains 37.0 ± 0.1 28.0 ± 0.1
A0A2S1KKZ9 a,c
W0G5P7
Malaysia 1969
Colombia 2015
Brazil 2015
Asian strains 31.0 ± 0.1 29.0 ± 0.1
H8XX11
A0A127AM58
A0A0X9QZM7
Micronesia 2007 Asian strain 36.0 ± 0.1 29.0 ± 0.1 B3U3M3
a Even though the samples were from approximately the same locations in 1947, they represented two separate
isolates. While the two isolates are classified as the MR-766 strain, the shell disorder data pointed out a unique
difference between these two isolates. b Isolate: ZIKV/Macaca mulatta/UGA/MR-766/1947-East_African. c Isolate:
ZIKV/Macaca mulatta/UGA/MR-766-VEROE6-AC4-P12_07/1947. d The standard error is denoted by the prefix “±”.
Figure 1. Correlations between fetal morbidity/mortality and shell disorder (M and C Protein PIDs).
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(A) Correlation between fetal morbidity and ZIKV–Dengue virus 2 (DENV-2) shell disorder (regression:
r2 = 0.8, F = 16, p < 0.01; independent variables: C and M PIDs). See Figure S1 for more details on the
data points; (B) correlation between flavivirus case fatality ratio (CFR) and shell disorder (regression:
r2 = 0.8, F = 29, p < 0.01; independent variables: C and M PIDs). With the exception of the ZIKV data,
much of the data can be found in a previous publication [25].
While Figure 1A and Table 1 involve the determination of the correlation between the fetal
morbidity associated with ZIKV infection and ZIKV shell disorder (PID), Figure 1B and Table 2 represent
the results of the analysis of the correlation between the case fatality ratio ((CFR), i.e., virulence) and the
shell disorder of various flaviviruses, including ZIKV. Information on the CFRs of various flaviviruses
is publicly available [14,57–60]. Because the symptoms of ZIKV are usually very mild and fatalities are
extremely rare, for a long time, the virus was shrouded in mystery [2,3].
It is therefore likely that the CFR is very close to zero, even if most of the currently available data
are those from infections arising in the Americas, which involved strains of Asian lineage, not African
lineage [1,4–6]. A strong correlation was found between flavivirus CFR and shell disorder, as seen in
Figure 1B and Table 2. While a correlation between flavivirus CFR and shell disorder has already been
reported [2,14], the data presented here include results for ZIKV, which was not previously considered.
Table 2. Mean PID of C and M proteins by flavivirus with UniProt accession codes (regression: r2 = 0.9,
F = 18, p < 0.01; independent variables: C and M PIDs; dependent variable: CFR) [25].
Virus CFR a,b,c C PID a,b M PID a,c UniProt ID
YFV >50% 74 ± 1d 35 ± 1d P03314, Q6DV88, Q1X881
TBEV-Fe 20–40% 68 ± 3 8.0 ± 0.1 G5CP55, P07720, K4P8A
TBEV-Si 2–3% 63 ± 1 6.0 ± 0.1 G8FGD9, G8FGD9
TBEV-Eu 1–2% 62 ± 2 6.0 ± 0.1 Q01299, P14336
DENV1-4 1.4 ± 0.8% 47 ± 5 11 ± 5 P14337, P09866, Q58Ht7
WNV ~0.4% 49 ± 4 9.0 ± 0.1 Q9EMB5, Q53AP1, P06935
ZIKV <0.2% 35 ± 6 28.7 ± 0.5 P14336, Q32ZE1, H8XX11
a A regression model using CFR as the dependent variable with M and C PIDs as independent variables yielded r2 =
0.8, F = 29, p < 0.01. Interaction between the two independent variables was seen as statistically significant. The PID
are in percentages (%). b A regression model using CFR as the dependent variable with C PID as the independent
variable yielded r2 = 0.3, F = 6, p < 0.05. c A regression model using CFR as the dependent variable with M PID as
the independent variable yielded r2 = 0.4, F = 9, p < 0.05. Tick-borne encepthalitis virus(TBEV). d The standard error
is denoted by the prefix “±”. YFV: yellow fever virus; WNV: West Nile virus.
3.2. C and M Proteins Play Roles in Virulence and Morbidity
In a previous study, we established that both C and M proteins play roles in flavivirus virulence,
as represented by CFR [25]. According to our research on other viruses, the capsid association with
virulence involves a mechanism of protein promiscuity, whereby intrinsic disorder allows the capsid
protein (the C protein, in the case of flaviviruses) to bind to a greater number of proteins, thereby allowing
the virus to multiply more rapidly before the host immune system can take action [2,14,51]. The matrix
protein (the M protein in flaviviruses), on the other hand, is likely to play a somewhat different role.
A more disordered matrix allows the virus to penetrate organs, namely vital organs, as in the case
of HIV-1, but still be able to evade the host immune systems via matrix and surface glycoprotein
motions [14,46,52].
A closer look at Tables 1 and 2 and Figure 1 reveals other specific trends. As in previous studies,
the PID of the C protein, as the sole independent variable, provided a weaker correlation with flavivirus
CFR that was of statistical significance (r2 = 0.3, F = 6, p < 0.05). Similarly, the PID of the M protein,
as the sole independent variable, also did not provide a very strong correlation with flavivirus CFR,
even if this correlation was statistically significant (r2 = 0.4, F = 9, p < 0.05). The use of PIDs of both M
and C proteins as independent variables, on the other hand, gave a strong correlation with flavivirus
CFR that was definitely stronger than the PIDs of C or M proteins alone (r2 = 0.38, F = 14, p < 0.01,
Figure 1B). Obviously, both M and C proteins complement each other in their combined contributions
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to virulence, which can be seen in both Figure 1B and Table 2. There was also a statistically significant
interaction between the two factors (p < 0.01).
3.3. Regions of Disorder in the M Protein: ZIKV versus YFV and DENV-2
Figure 1 and Tables 1 and 2 demonstrate that ZIKV is a peculiar virus, since it has a relatively
disordered M protein but also a relatively ordered C protein. This accounts for the ZIKV characteristics
of low mortality rates and yet high fetal morbidity rates. However, the use of PID values is inadequate
in providing a closer look at the differences in the disordered regions among the various viruses.
Figures 2 and 3 provide us with the opportunity for a detailed look at the disorder differences by region
of the proteins among several flaviviruses.
Figure 2A shows that disordered regions of the M proteins of ZIKV and YFV are relatively large
and overlap. With the disordered regions being found mostly around the N-termini of the M proteins
of the three flaviviruses shown, a much shorter disordered region is found in the DENV-2 M protein.
These observations could be used as a template for designing a ZIKV vaccine, especially when looking
at the PONDR VLXT plot of the ZIKV M protein. The asterisk (*) in Figure 2 shows areas that could be
potential targets in the development of a ZIKV vaccine.
Figure 2. Cont.
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Figure 2. Comparative PONDR VLXT plots of the M and C proteins from various flaviviruses,
including ZIKV. (A) M proteins of ZIKV (UniProt: A0A127AM58), DENV-2 (UniProt: P29990), and YFV
(UniProt: Q1X881). (B) C proteins of ZIKV (UniProt: H8XX11, Msia69, see Table 1), WNV (UniProt:
Q9Q694), and DENV-2 (UniProt: P29990). Regions with scores of 0.5 or above represent disorder.
Disorder differences between C proteins can be traced mainly to mutations and disorder near the
N- and C-termini. The regions with an asterisk (*) denote potential targets for the development of a
ZIKV vaccine. With the exception of Msia69 (Malaysia 1969) ZIKV, the strains were randomly chosen.
Msia69 was deliberately chosen as a representative Asian strain that has a low C PID. The YFV M
protein was chosen for (A), since it has one of the highest PIDs among flaviviruses. WNV was not
necessary for (A), as specific strains of DENV-2 have an even lower M PID (PID: 6%) than does the ZIKV
(PID: 9%). On the other hand, WNV was chosen for (B), as the low WNV C PID (among flaviviruses)
allows us to suggest strategies for ZIKV vaccine development.
3.4. PONDR VLXT Plot for C Proteins from ZIKV and Other Flaviviruses
The PONDR VLXT plot for the C proteins of three flaviviruses, ZIKV, DENV-2, and WNV, can be
found in Figure 2B. As mentioned, studies have shown that disorder in the inner shells of viruses in
general tend to be associated with greater virulence because of the ability of proteins to bind more
promiscuously, thus providing the viruses with greater ability to replicate more rapidly. Similarly,
Figure 1B and Table 2 suggest that the reason that the ZIKV’s CFR is extremely low has to do with
the relatively low mean PID of its C protein (35 ± 6%, CFR ~0). While these results tell us about the
differences with regard to the mean C PIDs among the various flaviviruses, they do pinpoint the
disorder differences among the various flaviviruses along the entire stretch of the various flavivirus C
proteins, especially with respect to ZIKV. Figure 2B attempts to address this problem by showing that
the disorder differences between C proteins from ZIKV and other flaviviruses lie in two areas near the
N- and C-termini, respectively.
3.5. PONDR VLXT Plot for C Proteins from Different ZIKV Strains
While Figure 2B, Figure 1B, and Table 2 provide evidence that disorder in the C protein
contributes to the virulence of flaviviruses, Figure 1A, Figure 2A, Figure 3, and Table 1
point to the contribution of ZIKV C protein disorder to fetal morbidity. More specifically,
a rather large disordered region is missing near the N-terminus of the strains of Asian lineage,
which, as already mentioned, inflict morbidity to fetuses at a lower rate than do their African
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counterparts. There are also two distinct patterns of disorder for the two separate groups of
MR-766-like strains (ZIKV/Macaca mulatta/UGA/MR-766-VEROE6-AC4-P12_07/1947 vs ZIKV/Macaca
mulatta/UGA/MR-766/1947/East_Africa) shown in Table 1.
While Figure 3A reports that the residues that are disordered only in the MR-766-related strains can
be found near the N-terminus, Figure 3B identifies the residues responsible for the disorder differences.
The residues marked with “X” represent mutations. In general, the more polar and charged residues
tend to induce more disorder, and such can be observed in this case. Disorder differences between C
proteins from the Asian and African lineages can be traced mainly to mutations and disorder near
the N-termini.
Figure 3. (A) Comparison of intrinsic disorder predisposition of the C protein in ZIKV strains.
PONDR VLXT plot of C proteins from different ZIKV strains. (B) Mutations and disorder of the
N-terminus of the C proteins of the Afri47, Afri76, and Msia69 (the Africa 1947, Africa 1976, and Malaysia
1969 strains, respectively; Afri47 is the ZIKV/Macaca mulatta/UGA/MR-766/1947-East_African isolate;
see Table 1 for further details) strains. Disorder differences between C proteins from the Asian and
African lineages can be traced mainly to mutations and disorder near the N-termini.
3.6. The Roles of M Versus PrM and Pr in Protecting the Virion at Various Stages
The structure of immature flaviviruses is somewhat different from mature ones. An immature
flavivirus virion includes a precursor membrane protein, PrM. During maturity, the PrM is cleaved
such that the M remains as the membrane protein. This characteristic raises important questions about
the roles of PrM and M proteins, especially with regard to protecting the virion.
While such roles have seldom been explored in the past, hints of the potential roles of PrM and M
proteins can be found in the PID values obtained in this study. We have seen that with the exception
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of YFV and ZIKV, most other flaviviruses have highly ordered M proteins to protect their respective
mature virions (Figure 1B and Table 2). Figure 4A shows that the M protein is relatively more disordered
(in red) than in DENV-1 (Figure 4B). As with the PONDR VLXT plots in Figure 2, the disordered
regions of both ZIKV and DENV-1 are restricted to segments near the N-termini. While we have seen
that the M proteins of ZIKV and YFV are relatively disordered, the same cannot be said about Pr.
The Pr proteins for YFV and ZIKV are quite ordered, as seen in Figure 4C–E. The Pr disorder levels are
relatively low for most flaviviruses [2,25], as seen in the cases of ZIKV, DENV, and WNV. With Pr being
mostly ordered for most flaviviruses and M being the same for most flaviviruses (with the exception of
YFV and ZIKV), one can conclude that both Pr and M contribute to the order of the PrM proteins for
most flaviviruses, and this is especially important with respect to protecting the immature virion.
The following question then arose: How do ZIKV and YFV protect their immature virion given
their abnormally high M disorder? A hint to the answer to this question lies in the PID of their Pr
proteins. As we can see in Figure 4C–E, the Pr proteins of both ZIKV and YFV are quite ordered, well
within the range of most flaviviruses. As a result, fairly ordered PrM proteins are seen in both ZIKV
and YFV. The study therefore shows that the immature virions of ZIKV and YFV are more protected
against environmental insults than are their corresponding mature virions, which could suggest a
slightly different life cycle for YFV and ZIKV.
Figure 4. Cont.
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Figure 4. A comparison of M and PrM proteins (membrane and precursor membrane proteins) among
the various flaviviruses. (A) Three-dimensional structure of the ZIKV M protein, with disordered
regions represented in red. (B) Cryoelectron microscopy structure of the DENV-2 M protein (with
disorder annotation). (C) Crystal structure of YFV Pr, with disorder annotated in red. (D) Cryo-EM
(cryogenic electronic microscopy) structure of ZIKV Pr, with disorder annotated in red. (E) A comparison
of Pr, M, and PrM among the various flaviviruses. PrM and M proteins protect the immature and
mature virions, respectively.
While mature viruses are of course infectious, experimental evidence has suggested that fully
immature flaviviruses are generally not infectious, even if they may become infectious upon interactions
with antibodies [61]. Partially mature viruses are likely more infectious than fully immature ones [62].
ZIKV and YFV could therefore rely more on lesser mature viruses for their spread, given our evidence
showing that their virions become more delicate upon maturation.
4. Discussion
4.1. Virulence and Disorder from Inner and Outer Shells: Clues from Other Viruses
The data in Figures 1–4 and Tables 1 and 2 show correlations between the intrinsic disorder
predisposition of proteins from the inner and outer shells and mortality and fetal morbidity rates.
This flavivirus-wide statistical study shows that both M and C proteins play roles in pathogenesis.
Similarly, the statistical analyses reveal that disorder in both the C and M proteins also contributes to
fetal morbidity.
4.2. A Lesson from HIV: Disordered Outer Shell Provides Better Viral Penetration of Vital Organs
The regression analysis reported here suggests the presence of interaction effects between C
and M PIDs. Given these observations and the fact that similar proteins play similar roles even
among nonrelated viruses, what do other viruses have to offer with respect to clues about trends in
the correlation between virulence and shell disorder? While very few viruses have shown positive
correlations with statistical significance between their virulence and membrane/matrix disorder (as the
sole independent variable), HIV offers a unique insight into the role of the matrix (membrane) protein.
Of the HIV and simian immunodeficiency virus (SIV) family, the HIV-1 matrix has the greatest known
PID [46,52]. HIV-1 and its closest sibling, SIVcpz, are the most pathogenic when compared to their
other cousins and siblings, including HIV-2. HIV-1 patients are known to have much greater viral loads
in their bloodstream than patients with HIV-2. Without the help of retroviral drugs, over 90% of HIV-1
patients would die within 10 years of the infection, whereas those infected with HIV-2 take a much
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longer time to succumb to the disease, if at all [46,63]. The roles of the matrix protein in virulence have
to do with viral ability to evade the host immune system and also the ability to bind promiscuously
to more host proteins [18,19,21,22]. An important characteristic of HIV is its ability to penetrate vital
organs, including the brain, with ease [14]. Apparently, the promiscuous binding potential arising
from the disordered matrix shell allows HIV to have easier access to specialized cells. We shall use this
argument again in the cases of ZIKV and YFV, which have high PIDs for their M proteins (28.6 ± 0.5%
and 35 + 1%, respectively).
4.3. Virulence and Inner Shell Disorder Involve a Different “Trojan Horse” Strategy in Immune Evasion
While disorder in the matrix shell is associated with virulence and the immune evasion found
in HIV, disorder in the inner shell (capsid or nucleocapsid) of other viruses, such as Ebola virus and
Nipah virus), is often also strongly associated with virulence [45,51]. Virulence arising from disorder
in the inner shell involves a different strategy of immune evasion, which can be referred to as Trojan
horse, since the virus attempts to replicate rapidly before the host immune system is able to recognize
its presence [2,14]. It does so by using the disordered inner shell proteins that play important roles in
the replication of the virus, where disorder assists the process by allowing for greater promiscuous
(and therefore more efficient) binding of host proteins.
4.4. Taking Turns to Protect the Virion from Environmental Insults
Curiously, a conflicting trend has also been observed in HIV: when the outer shell is disordered,
then the inner shells tend to be more ordered [14,52]. Conversely, if the outer shell is more ordered,
the inner shells tend to be more disordered. These conflicting trends can be seen in a variety of viruses,
including Nipah, corona, and Ebola viruses, not just HIV [2,45,49–51]. The reason for this has to do
with the fact that both shell layers play their roles in protecting the virion from environmental insults.
If the outer layer is more disordered, the inner layer compensates by being more ordered. If, on the
other hand, the outer layer is more ordered, the inner layer, depending on the type of environment the
virus is exposed to, has the luxury of being less ordered.
4.5. Conflicting Trends Can Be Found among Flaviviruses: Protecting the Virion Versus Immune Evasion
The two aforementioned seemingly conflicting trends that are seen in other viruses can also be
observed in flaviviruses and ZIKV. It is for this reason that we observed statistical significance in the
interaction effects between the PIDs of C and M proteins as independent variables. Furthermore, strong
flavivirus CFR correlations were not attainable until both C and M PIDs were used as independent
variables (r2 = 0.8, F = 29, p < 0.01). A closer look at the data in Figure 1B allows us to conclude that
some flaviviruses do indeed have more ordered M proteins when their C proteins are disordered
and vice versa. For example, tick-bone encephalitis virus (TBEV) viruses have higher PIDs in their
C proteins than do DENV viruses, but they have lower PIDs for M proteins. Similarly, ZIKV has a
low PID value for C but a high PID for M. There is also evidence of this trend within ZIKV strains
themselves: we can notice a slightly lower M disorder in MR-766 strains (PID: 28 vs 29%, Table 1)
despite their higher C PID values even as M PIDs remain relatively high for all ZIKV strains.
This trend is, however, not the case with every flavivirus. A striking exception is YFV,
which provides some evidence for the other trend that involves strategies of immune evasion
using disorder in either or both M and C shells. More specifically, disorder in M and C proteins is likely
to play different but complimentary roles in maintaining higher viral load, especially in vital organs
necessary to evade the immune system, and YFV is somewhat unique in using both C and M disorder
to a much greater extent than other flaviviruses do. This will be further described in the next section.
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4.6. YFV Uses both Inner and Outer Shell Disorder to Evade Immune Systems, Resulting in
High Pathogenicity
Relative to other flaviviruses, YFV is characterized by highly disordered C and M proteins.
Two modes of action are at work here. A highly disordered YFV has an overwhelmingly high PID in
its C protein (~75%). Interestingly, the mean PID of its M protein (~35%) was also far higher than the
corresponding values for all other flavivirus species found in our sample. It is likely that the highly
disordered C protein allows for more rapid replication via its promiscuity in protein binding. As a
result of the rapid replication, greater viral loads are more attainable, leading to greater virulence.
A higher disorder in the M protein, however, allows the virus to more easily penetrate different organs,
including vital organs such as the liver [2,15]. Apparently, YFV’s extremely high pathogenicity, which
reaches above a 50% CFR, arises from its unique ability to utilize disorder from both its M and C
proteins to maintain a viral load as a means of evading the immune system.
4.7. The Shell Disorder Model Predicts Correctly that ZIKV Is Able to Penetrate Vital Organs with
Greater Efficiency
While YFV has greater disorder in both its M and C proteins, ZIKV offers us a unique opportunity
to study a flavivirus with a high PID in its M protein (35 ± 6%) but a low PID in its C protein (28.6
± 1%). If we use the aforementioned model based on our knowledge of shell disorder, the model
will predict ZIKV as a virus that is of low pathogenicity but has the ability to penetrate vital organs.
This prediction is extremely accurate in the case of ZIKV. We are able to see that ZIKV infection is
usually nonfatal, with CFR being close to 0%, but ZIKV also has an uncanny ability to penetrate the
brain and placenta, as seen in its ability to cause microcephaly [12].
4.8. ZIKV C PID Variation Correlates with Fetal Morbidity: A “Trojan Horse”
We have seen that flaviviruses use disorder in M and C proteins to evade host immune systems.
YFV uses both M and C to penetrate vital organs and proliferate rapidly. The two modes become
a deadly mix. The ZIKV uses its high M disorder to penetrate the placenta and brain, but we have
also noticed that, while ZIKV C PID values are generally low, there is noticeable variation in the C
PIDs seen in the different lineages and strains. This PID variation in the C protein correlates with
fetal morbidity that is dependent on the lineage of ZIKV. The results fit perfectly with what has been
observed in other viruses. The “Trojan horse” theory tells us that the higher C disorder allows for more
efficient proliferation of the virus in the larger variety of organs that it is able to penetrate [2,49].
4.9. Evolution of ZIKV Variation in Fetal Morbidity Is Dependent on the Optimal Viral Load Necessary for
More Efficient Transmission Among Its Primary Primate Hosts
While variation in ZIKV M PID is only 1%, ZIKV C PID can be as low as 31% and as high as 45%.
Inspection of the PONDR VLXT plot shows that the disordered regions lie in both the N- and C-termini
even if the ZIKV C mutations arise entirely within the N-terminus (Figure 3). This provides clues to the
evolution of ZIKV with respect to its ability to cause fetal morbidity in its hosts. It is likely that ZIKV
had to evolve with the primate species that it most commonly infects. For certain primate hosts, it finds
greater fitness when a greater viral load is necessary for it to infect a larger number of hosts because of
the peculiarities found in the hosts’ immune system: having a more disordered C protein does the trick.
It is therefore likely that the different PIDs of C proteins from the various ZIKV strains and lineages
are the result of the types of primates that the peculiar ZIKV strain primarily infects and its ability to
fine-tune its C disorder to meet the optimal viral load necessary for more efficient transmission of the
virus in a given host, as seen in the case of other viruses and other flaviviruses [2,14,25,39,49,50].
Biomolecules 2019, 9, 710 14 of 18
4.10. Experimental Evidence for the Role of C and M Proteins in Replication and Immune Evasion: Roles
for Disorder
Experiments do provide evidence pointing to the important roles of C and M proteins in replication
and immune evasion. Flavivirus protein C, along with other viral proteins, assists in the assembly and
packaging of viral particles during replication, in addition to assisting the protein M to move to the
endoplasmic reticulum (ER). Additionally, the C protein is trafficked to the nucleus through binding
with importin [64]. Upon doing so, it interacts with histones to force the cell to stay longer in the G1
stage of the cell cycle so as to buy more time for viral replication [65]. In the cytoplasm, protein C binds
to the Sec3 protein in order to inhibit Sec3 proteasomal antiviral activity [66].
As for the M protein, there is still much to be uncovered about its functions. It is, however, known
that PrM binds to the ER for two reasons. It protects the E proteins from damage by host enzymes via
the formation of a beta barrel [67]. The other reason is that PrM prevents E from being so embedded
in the host membrane that it cannot be removed in the later stages of the virion replication process.
While the Pr segment is ordered to protect E from the proteases, the greater flexibility of M in many
flaviviruses is likely needed to ensure greater efficiency in its binding to the ER.
Similarly, greater disorder in the C protein offers plenty of opportunity for greater binding
efficiency, given its aforementioned experimentally proven functions. For instance, the greater disorder
in the C protein could help its binding to histones with greater efficiency. Protein disorder not only
provides greater efficiency in protein–protein binding but also promotes the binding of proteins to
nucleic and fatty acids as well.
4.11. Clues for Developing a ZIKV Vaccine
Figure 3 reiterates the minimum requirements necessary in the development of a ZIKV vaccine:
the PID of the C protein has to be as low as possible. Figure 2B, on the other hand, suggests ways that
a ZIKV can be used for a ZIKV vaccine developed by comparing the PONDR VLXT plots of the ZIKV
C protein to those of other flaviviruses. More specifically, it shows a region near the C-terminus that is
ordered in WNV but disordered in ZIKV. This region could be a good target for the development of an
attenuated ZIKV, as it indicates a region that is not necessarily disordered but is still tolerated by a
cousin, WNV.
Just as relatively high disorder levels in the M protein (PID: 28%, 29%) are a hallmark of the ZIKV,
an effective vaccine needs to have an M protein with a lower PID so that an attenuated virus will not
penetrate the placenta of pregnant women. Figures 2A and 4 show that the disordered regions of the M
protein are near the N-terminus, and mutations to attenuate the virus must be in that region. Since the
M protein of DENV has a much shorter disordered region (Figures 2B and 4A,B), Figure 2A identifies
an area that is ordered in DENV and would be a good target of mutations during the development
of an attenuated ZIKV. Again, since that region is ordered in DENV-2, order there could be tolerated
by ZIKV.
5. Conclusions
There were two main ZIKV oddities discovered in this research. The first has to do with the
relatively high disorder in the ZIKV M protein, which is at a level that is seldom found among other
flaviviruses, with the exception of YFV. The other is the somewhat large variation in the disorder of
ZIKV depending on the strain and lineage of the virus. These oddities are consistent with what we
now know as characteristics of ZIKV. Just as other viruses (such as WNV and HIV-1) that have high
outer shell (matrix/membrane) PIDs are able to penetrate vital organs, ZIKV can also penetrate the
placenta and brain [12]. Furthermore, scientists have discovered that strains of the African lineage
possess a greater potential to cause fetal morbidity. This fact correlates with the variations in the
disorder levels of the ZIKV C protein. Disorder in the inner shell has already been associated with
virulence and higher viral loads in other flaviviruses and other unrelated viruses, such as in the Ebola
and Nipah viruses.
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There are important implications for these findings. The results presented here could lead to
the development of a new vaccine through the creation of attenuated strains resulting from more
ordered C and M proteins. The regions for potential vaccine targets are disordered regions of the ZIKV
M and C proteins that are ordered in other flavivirus species. Exploration of a ZIKV vaccine could
include mutations in these areas. Other applications could include building a more comprehensive
model that could anticipate the behaviors of new or little-known viruses. Lastly, the ability of ZIKV
and YFV to penetrate vital organs as a result of shell disorder adds to a growing body of knowledge
that encompasses a variety of viruses, such as HIV, that use such strategies to enter or to hide in
hard-to-reach organs. An important potential application of this is in the field of cancer oncolysis,
which involves the use of viruses to “attack” tumors, since both share the same pathways [68,69].
Viruses could be engineered to evade host immune systems that impede the effectiveness of therapeutic
viruses. Moreover, since cancers in hard-to-reach organs such as the brain are often problematic for
virotherapies and chemotherapies [14,70], a better understanding of the roles of shell disorder in the
viral penetration of such organs will lead to improved therapies.
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